Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,856
datasets available to search
ShareScore release 0.9.0
Dataset results
5,856 results for “B cells”
TCR Reserved and Power3 (SPPL3) Gene Knock-out Allogeneic CD19-targeting CAR-T Cell Therapy in r/r B Cell Lymphoma
ClinicalTrials.gov study NCT06323525. IPD Sharing: NO. Countries: 1. Publications: 0.
SAR3419 Administered Weekly in Patients With Relapsed/Refractory CD19-positive B-cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00796731. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Study of Anti-CD19 CAR NK Cells in the Treatment of Relapsed/Refractory Diffuse Large B Cell Lymphoma
ClinicalTrials.gov study NCT05673447. IPD Sharing: NO. Countries: 1. Publications: 0.
Toripalimab Combine With Rituximab for Treatment of Relapsed Refractory CD20 Positive Diffuse Large B-cell Lymphoma
ClinicalTrials.gov study NCT04425824. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Study of Pegylated Liposomal Doxorubicin Contrast Epirubicin for the Treatment of Diffuse Large B-cell Lymphoma
ClinicalTrials.gov study NCT03022123. IPD Sharing: NO. Countries: 1. Publications: 0.
Efficacy and Safety of Chemotherapy Combined With CAR-T Cells in Newly Diagnosed Adult Patients With Ph- B-ALL
ClinicalTrials.gov study NCT06481241. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Evaluation of Hypertension Management and Cardiovascular Adverse Event Prevention in Patients With B-cell Malignancies Undergoing Treatment With Bruton Tyrosine Kinase Inhibitors, the HALT Study
ClinicalTrials.gov study NCT06151730. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Venetoclax and a Pediatric-Inspired Regimen for the Treatment of Newly Diagnosed B Cell Acute Lymphoblastic Leukemia
ClinicalTrials.gov study NCT05157971. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Efficacy of ThisCART19 in Patients With Refractory or Relapsed B Cell Malignancies
ClinicalTrials.gov study NCT04384393. IPD Sharing: NO. Countries: 1. Publications: 0.
Clinical Study of Multi-targeted CAR-T Therapy in Patients With Relapsed/Refractory B-Cell Lymphoma
ClinicalTrials.gov study NCT07093086. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Basic-clinical Translational Research in Hepatitis B Virus (HBV)-Specific Antigen Peptides and HepG2 Cell Lysate Co-activated Dendritic Cells Combined With Transarterial Chemoembolization (TACE) in
ClinicalTrials.gov study NCT03086564. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell Lymphoma
ClinicalTrials.gov study NCT05272384. IPD Sharing: YES. Countries: 1. Publications: 0.
Bryostatin 1 and Rituximab in Treating Patients With B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00087425. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Microtransplantation and Checkpoint Blockade Immunotherapy for Relapsed or Refractory B Cell Lymphomas
ClinicalTrials.gov study NCT03920631. IPD Sharing: NO. Countries: 1. Publications: 0.
A Clinical Research of CD22-Targeted CAR-T in B Cell Malignancies
ClinicalTrials.gov study NCT02935153. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Safety and Efficacy of ThisCART22 in Patients With Refractory or Relapsed B Cell Malignancies
ClinicalTrials.gov study NCT04601181. IPD Sharing: NO. Countries: 1. Publications: 0.
Bridging Allogeneic Hematopoietic Stem Cell Transplantation or Not After CD19 CAR - T (S1904) Cell Therapy for r/r B-cell Acute Lymphoblastic Leukemia
ClinicalTrials.gov study NCT06581081. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Drug-drug Interaction Study of Ofatumumab With Bendamustine in Subjects With Indolent B-cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT01691807. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase Ib/II Study of the Efficacy and Safety of the R-CMC544/R-GEMOX Combination in Diffuse Lage B-cell Lymphoma at First or Second Relapse
ClinicalTrials.gov study NCT01562990. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Study of IOMAB-ACT Followed by CAR-T Cell Therapy for Patients Relapsed or Refractory (Diffuse Large B-cell Lymphoma
ClinicalTrials.gov study NCT06768905. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.